Hi all,
Last week saw an incredible meeting of the minds across the domestic and international pain specialist community – with the 2022 New Zealand Pain Society Conference, where Exsurgo was proud to be platinum sponsor.
Our very own Chief Science Officer Christine Ozolins took the virtual stage to present how EEG has the potential to be a game-changer for non-pharmaceutical pain relief interventions. Christine’s talk generated immense interest in our product and sparked a range of questions on Axon. We have curated a list of FAQs from the conference and answers on our blog here for all those who may be curious to know more.
It was an incredible opportunity to be front and centre of forward-thinking discussions under the theme “All Hands On Deck’ – a rallying call to bring together New Zealand and international pain specialists to improve the industry’s understanding and treatment of pain. I welcome anyone interested in knowing more about the rollout of our technology to get in touch via our website.
Looking ahead, our larger clinical trial of Axon continues to progress with more Kiwi trialists and we’re set to launch a series of smaller case studies overseas in the coming months.
Stay well as we enter the cooler Autumn months.
Kind regards,
Richard
Proudly sponsoring the NZ Pain Society conference
Last week, Exsurgo was the proud platinum sponsor of the 2022 NZ Pain Society Conference, a 4-day virtual event that aimed to combine the best New Zealand and international thinking that moves the sector forward.
Our Chief Science Officer Christine Ozolins took the virtual stage to discuss chronic pain in relation to neurofeedback and how our Axon system aims to bring a viable alternative solution. She explained how chronic pain functions in relation to our brain structure and how our Axon system helps to elevate alpha brain waves to help alleviate pain, combat depression and reduce anxiety.
Another session we found incredibly interesting was John Moffat’s presentation on how Acceptance and Commitment Therapy (ACT) can be used to treat chronic pain and overcome the split between our body and mind.
ACT is rooted in the belief that society teaches us pain is a biomedical problem that should be treated with a biomedical solution. Chronic pain sufferers know all too well that often their pain cannot be easily treated with medication alone on a long term basis, requiring us to reframe how we think of pain and its role in our life.
ACT practitioners like John encourage patients to let go of the ‘tug-of-war’ with the monster of pain and focus on living as well as possible, despite the pain. Although challenging, this work has helped many people to re-discover what matters most to them and find practical ways to live out their values every day.
As a major supporter of the conference, it was great to see the ground-breaking work and commitment of so many in the exploration and treatment of pain.